We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
95 hedge funds and large institutions have $110M invested in ADMA Biologics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
0% more funds holding
Funds holding: 95 → 95 (0)
2.97% less ownership
Funds ownership: 56.51% → 53.54% (-3%)
22% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.05M
23% less capital invested
Capital invested by funds: $143M → $110M (-$32.8M)
36% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 39
Holders
95
Holders Change
–
Holders Change %
0%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
25
Reduced
39
Closed
17
Calls
$1.6M
Puts
$2.05M
Net Calls
-$452K
Net Calls Change
-$244K
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$3.02M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.48M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$2.09M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.21M |
| 5 |
Millennium Management
New York
|
-$798K |
